Remove Embolism Remove Peripheral Arterial Disease Remove Pulmonary
article thumbnail

SCAI Scientific Sessions 2025 to Feature Presentations on TAVR, PAD and PE 

DAIC

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52
article thumbnail

Education and cardiovascular diseases: a Mendelian randomization study

Frontiers in Cardiovascular Medicine

Specifically, this genetic factor was found to lower the risk of type 2 diabetes by 46.5%, coronary heart disease by 37.5%, ischemic stroke by 35.4%, cardiac-related mortality by 28.6%, heart failure by 28.2%, transient ischemic attack by 24%, atrial fibrillation by 15.2%, peripheral artery disease by 0.3%, and hypertension by 0.3%.

article thumbnail

Focus on Intervention | SCAI 2024: Six Takeaways For Practice

American College of Cardiology

Here are my takeaways for what's likely to affect practice in the short and medium-term.

article thumbnail

CircRNA-mediated regulation of cardiovascular disease

Frontiers in Cardiovascular Medicine

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.